• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Impact of prolonged utilization of neprilysin inhibition on the cognitive function of heart failure patients.

作者信息

Shah Niel N, Dogar Muhammad U, Shah Parin N, Ishtiaq Sameera, Mathew Shawn, Shah Pratik, Ishtiaq Alia, Vittorio Timothy J

机构信息

Smt. N.H.L. Municipal Medical College, Ahmedabad, Gujarat, India.

Crozer-Chester Medical Center, Chester, PA, USA.

出版信息

Ther Adv Cardiovasc Dis. 2018 May;12(5):135-139. doi: 10.1177/1753944718756563. Epub 2018 Mar 13.

DOI:10.1177/1753944718756563
PMID:29529959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5941672/
Abstract
摘要

相似文献

1
Impact of prolonged utilization of neprilysin inhibition on the cognitive function of heart failure patients.长期使用中性肽链内切酶抑制剂对心力衰竭患者认知功能的影响。
Ther Adv Cardiovasc Dis. 2018 May;12(5):135-139. doi: 10.1177/1753944718756563. Epub 2018 Mar 13.
2
Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: A meta-analysis of randomized controlled trials.联合应用 Neprilysin 和 RAS 抑制剂治疗心力衰竭的疗效和安全性:一项随机对照试验的荟萃分析。
Int J Cardiol. 2019 Oct 15;293:159-164. doi: 10.1016/j.ijcard.2019.05.048. Epub 2019 May 23.
3
Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure.血管紧张素受体-中性内肽酶抑制在心力衰竭中的作用
Curr Atheroscler Rep. 2016 Aug;18(8):48. doi: 10.1007/s11883-016-0603-4.
4
Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.联合血管紧张素II受体1拮抗作用与中性肽链内切酶抑制作用治疗心力衰竭。
Expert Rev Clin Pharmacol. 2016 Apr;9(4):513-523. doi: 10.1586/17512433.2016.1153423. Epub 2016 Feb 29.
5
Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.可溶性 Neprilysin 可预测心力衰竭患者的心血管死亡和心力衰竭住院。
J Am Coll Cardiol. 2015 Feb 24;65(7):657-65. doi: 10.1016/j.jacc.2014.11.048.
6
Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides.心力衰竭中的 Neprilysin 抑制:除了调节利钠肽之外的机制和底物。
Eur J Heart Fail. 2017 Jun;19(6):710-717. doi: 10.1002/ejhf.799. Epub 2017 Mar 21.
7
Leptin-Aldosterone-Neprilysin Axis: Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity.瘦素-醛固酮-脑啡肽酶轴:鉴定其在肥胖人群心力衰竭三种表型发病机制中的独特作用。
Circulation. 2018 Apr 10;137(15):1614-1631. doi: 10.1161/CIRCULATIONAHA.117.032474.
8
Altered serum levels of neprilysin in heart failure patients with reduced ejection fraction.心力衰竭射血分数降低患者血清脑啡肽酶水平的改变。
Bratisl Lek Listy. 2021;122(1):28-33. doi: 10.4149/BLL_2021_002.
9
Augmentation of glucagon-like peptide-1 receptor signalling by neprilysin inhibition: potential implications for patients with heart failure.抑制脑啡肽酶增强胰高血糖素样肽-1 受体信号:对心力衰竭患者的潜在影响。
Eur J Heart Fail. 2018 Jun;20(6):973-977. doi: 10.1002/ejhf.1185. Epub 2018 Mar 30.
10
Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure.血浆 B 型利钠肽浓度升高可直接抑制心力衰竭患者循环中性肽酶活性。
JACC Heart Fail. 2015 Aug;3(8):629-36. doi: 10.1016/j.jchf.2015.03.011.

本文引用的文献

1
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.血管紧张素受体脑啡肽酶抑制剂治疗射血分数保留心力衰竭:PARAGON-HF 试验的原理和设计。
JACC Heart Fail. 2017 Jul;5(7):471-482. doi: 10.1016/j.jchf.2017.04.013. Epub 2017 Jun 26.
2
Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.PARADIGM-HF及其他射血分数降低的心力衰竭试验中与痴呆相关的不良事件。
Eur J Heart Fail. 2017 Jan;19(1):129-137. doi: 10.1002/ejhf.687. Epub 2016 Nov 20.
3
An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.一项全基因组转录组综合分析表明,坎地沙坦具有神经保护作用,是阿尔茨海默病的候选治疗药物。
Alzheimers Res Ther. 2016 Jan 28;8:5. doi: 10.1186/s13195-015-0167-5.
4
'Hearts and minds': association, causation and implication of cognitive impairment in heart failure.“心与智”:心力衰竭认知障碍的关联、因果关系及其影响。
Alzheimers Res Ther. 2015 Feb 27;7(1):22. doi: 10.1186/s13195-015-0106-5. eCollection 2015.
5
Neprilysin, cardiovascular, and Alzheimer's diseases: the therapeutic split?中性肽链内切酶、心血管疾病与阿尔茨海默病:治疗分歧?
Eur Heart J. 2015 Apr 14;36(15):902-5. doi: 10.1093/eurheartj/ehv015. Epub 2015 Jan 29.
6
Neprilysin inhibition for heart failure.用于心力衰竭的中性肽链内切酶抑制作用
N Engl J Med. 2014 Dec 11;371(24):2336-7. doi: 10.1056/NEJMc1412654.
7
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.血管紧张素受体脑啡肽酶抑制剂与依那普利比较,对心力衰竭存活患者临床进展风险的影响。
Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17.
8
Treatment of vascular risk factors in patients with a diagnosis of Alzheimer's disease: a systematic review.阿尔茨海默病患者血管危险因素的治疗:一项系统评价
BMC Med. 2014 Nov 11;12:160. doi: 10.1186/s12916-014-0160-z.
9
Neuroprotective effects of angiotensin receptor blockers.血管紧张素受体阻滞剂的神经保护作用。
Am J Hypertens. 2015 Mar;28(3):289-99. doi: 10.1093/ajh/hpu197. Epub 2014 Oct 31.
10
Hypertension and Alzheimer disease: another brick in the wall of awareness.
Hypertension. 2015 Jan;65(1):36-8. doi: 10.1161/HYPERTENSIONAHA.114.04257. Epub 2014 Oct 20.